Clinical Trial Update: Allopurinol to Prevent Cirrhosis Related Morbidities [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating allopurinol for prevention of cirrhosis-related morbidities has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Tanta University | Conditions: Cirrhosis | Phase 2, Phase 3 | Status: COMPLETED